EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Heart Failure in Young Women with Systemic Lupus Erythematosus

Vijayashree Gokhale, Divam Prakash Singh, Sangram Mangudkar, Satbir Kaur Malik

Annals of African Medicine · 2026-11 · 25 (Suppl 4) · S739-S745

DOI: 10.4103/aam.aam_391_26 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of African Medicine, online erschienen am 23.07.2026. Verfasst von Vijayashree Gokhale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India. Hauptthemen laut MEDLINE: Heart Failure, Lupus Erythematosus, Systemic, Myocarditis, Lupus Nephritis. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We present two cases (females aged 23 and 36 years) with newly diagnosed systemic lupus erythematosus who developed lupus myocarditis concurrent with lupus nephritis. Both exhibited acute decompensated heart failure with dyspnea, edema, and cardiomegaly. Common key findings included strongly positive ANA blot, nephrotic-range proteinuria, acute kidney injury, and markedly elevated NT-proBNP (>35,000 pg/mL). Transthoracic echocardiography confirmed biventricular dysfunction (left ventricular ejection fraction [LVEF]: 20%–35% initially), moderate-to-severe tricuspid regurgitation, moderate-to-severe pulmonary arterial hypertension, and mild pericardial effusions. Both received high-dose pulse dexamethasone (40–60 mg IV), hydroxychloroquine (HCQ), diuretics, beta-blockers, SGLT2 inhibitors, and HCQ. The fulminant case additionally underwent plasma exchange. Both the patients, over the next few weeks, received cyclophosphamide therapy and achieved LVEF recovery to 50%–55% within 1–2 months, with improved renal function and resolution of heart failure symptoms. These cases underscore the reversibility of lupus myocarditis with early aggressive immunosuppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureLupus Erythematosus, SystemicMyocarditisLupus NephritisHumansFemaleAdultImmunosuppressive AgentsYoung AdultEchocardiographyCyclophosphamideTreatment OutcomeNatriuretic Peptide, BrainPlasma ExchangePeptide Fragments

Stichwörter der Autor:innen

CyclophosphamidePLEXcorticothérapie par bolusheart failureinsuffisance cardiaquelupus myocarditislupus nephritislupus érythémateux systémiquemyocardite lupiquenéphrite lupiquepulse steroid therapysystemic lupus erythematosuséchanges plasmatiques

Substanzen

Immunosuppressive AgentsCyclophosphamideNatriuretic Peptide, Brainpro-brain natriuretic peptide (1-76)Peptide Fragments

Autor:innen und Institutionen

  • Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D.Y. Patil Vidyapeeth, Pune, Maharashtra, India.

Zitieren

APA

Gokhale, V., Singh, D. P., Mangudkar, S., & Malik, S. K. (2026). Heart Failure in Young Women with Systemic Lupus Erythematosus. Annals of African Medicine, 25(Suppl 4), S739-S745. https://doi.org/10.4103/aam.aam_391_26

Vancouver

Gokhale V, Singh DP, Mangudkar S, Malik SK. Heart Failure in Young Women with Systemic Lupus Erythematosus. Annals of African Medicine. 2026;25(Suppl 4):S739-S745. doi:10.4103/aam.aam_391_26

BibTeX
@article{Gokhale2026,
  author = {Gokhale, Vijayashree and Singh, Divam Prakash and Mangudkar, Sangram and Malik, Satbir Kaur},
  title = {Heart Failure in Young Women with Systemic Lupus Erythematosus},
  journal = {Annals of African Medicine},
  year = {2026},
  volume = {25},
  number = {Suppl 4},
  pages = {S739--S745},
  doi = {10.4103/aam.aam_391_26}
}
Kostenlos starten →